Perrigo picks up OTC brands from GSK

4 June 2015 - Deborah Wilkes

Archived

Perrigo is acquiring a portfolio of OTC brands from GlaxoSmithKline Consumer Healthcare, including nicotine-replacement therapy (NRT) products, cold and flu remedies, and cold-sore treatments. The deal includes the NiQuitin NRT business in Europe, Brazil and Turkey, as well as the Nicotinell NRT business in Australia.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: